Associate Professor, Medicine - Nephrology, Stanford University Medical Center
Nephrology
Dr. Wolfgang C. Winkelmayer, MD
|
|
Give Review
Wolfgang Winkelmayer works in the field of Nephrology. He received 1 awards: "Fellow (ASNF)". Wolfgang Winkelmayer is a published MD. He has 104 publications published. The most current publication "Epoetin Alfa and Outcomes in Dialysis amid Regulatory and Payment Reform." He is registered with Medicare.
Publications
- The Dawning of a New Day in CKD Anemia Care?
- Serious infections among adult medicaid beneficiaries with systemic lupus erythematosus and lupus Nephritis.
- Comparison of longer-term outcomes after Kidney transplantation between Hispanic and non-Hispanic whites in the United States.
- Detecting clinically meaningful biomarkers with repeated measurements: An illustration with electronic health records.
- Menopausal symptoms in women with chronic Kidney disease.
- Adiposity Patterns and the Risk for ESRD in Postmenopausal Women.
- Prevention of Acute kidney injury using vasoactive or antiplatelet treatment: three strikes and out?
- Use of novel oral anticoagulants in patients with end-stage Renal disease.
- Correlates and outcomes of warfarin initiation in Kidney transplant recipients newly diagnosed with atrial fibrillation.
- Commentary on 'The DOPPS Practice Monitor for US Dialysis Care: Potential Impact of Recent Guidelines and Regulatory Changes on Management of Mineral and Bone Disorder...
- Earlier- versus later-start peritoneal dialysis: not a moment too soon?
- Physician Visits and 30-Day Hospital Readmissions in Patients Receiving Hemodialysis.
- Correlates and variance decomposition analysis of heparin dosing for maintenance hemodialysis in older US patients.
- State Medicaid Coverage, ESRD Incidence, and Access to Care.
- Warfarin treatment in patients with atrial fibrillation and advanced chronic Kidney disease: sins of omission or commission?
- Cardiovascular Disease: Still unresolved: warfarin in ESRD with atrial fibrillation.
- Trends in Anemia Care in Older Patients Approaching End-Stage Renal Disease in the United States (1995-2010).
- Addressing Missing Data in Clinical Studies of Kidney Diseases.
- Prognostic Stratification in Older Adults Commencing Dialysis.
- Coronary artery bypass graft type and outcomes in maintenance dialysis.
- Erythropoiesis-stimulating Agent Use among Patients with Lupus Nephritis Approaching End-stage Renal Disease.
- Near-Term Prediction of Sudden Cardiac Death in Older Hemodialysis Patients Using Electronic Health Records.
- Differences in Access to Kidney Transplantation between Hispanic and Non-Hispanic Whites by Geographic Location in the United States.
- Predicting the Outcomes of Rhabdomyolysis: A Good Starting Point.
- Strategies for Postmarketing Surveillance of Drugs and Devices in Patients with ESRD Undergoing Dialysis.
- Multivessel coronary revascularization and outcomes in Kidney transplant recipients.
- Outcomes after Kidney transplantation of patients previously diagnosed with atrial fibrillation.
- Infection risk with bolus versus maintenance iron supplementation in hemodialysis patients.
- Fostering Innovation, Advancing Patient Safety: The Kidney Health Initiative.
- Temporal Trends in the Incidence, Treatment, and Outcomes of Hip Fracture in Older Patients Initiating Dialysis in the United States.
- Use and safety of heparin-free maintenance hemodialysis in the USA.
- The Comparative Short-term Effectiveness of Iron Dosing and Formulations in US Hemodialysis Patients.
- DETERMINANTS OF PERITONEAL DIALYSIS TECHNIQUE Failure IN INCIDENT US PATIENTS.
- Epidemiology and sociodemographics of systemic lupus erythematosus and lupus Nephritis among US adults with Medicaid coverage, 2000-2004.
- Variation in Nephrologist Visits to Patients on Hemodialysis across Dialysis Facilities and Geographic Locations.
- Assessments of Causal Effects--Theoretically Sound, Practically Unattainable, and Clinically Not So Relevant.
- More evidence on an abominable pairing: atrial fibrillation and Kidney disease.
- Epidemiologic and statistical methods for comparative effectiveness research.
- Trends in Acute kidney injury, associated use of dialysis, and mortality after cardiac surgery, 1999 to 2008.
- Preoperative statin use and postoperative Acute kidney injury.
- Anticoagulation for atrial fibrillation in patients on dialysis: are the benefits worth the risks?
- Predialyis nephrology care of older individuals approaching end-stage Renal disease.
- Prevalence, incidence, and demographics of systemic lupus erythematosus and lupus Nephritis from 2000 to 2004 among children in the US medicaid beneficiary population.
- Trends in the incidence of intestinal perforation in US dialysis patients (1992-2005).
- Commentary on 'The DOPPS Practice Monitor for US Dialysis Care: Trends Through April 2011': No Surprises Yet.
- Altitude and the risk of cardiovascular events in incident US dialysis patients.
- What Caused Excess Strokes in Patients Randomized to Darbepoetin in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)?: No Smoking Gun.
- Prevalence of atrial fibrillation and warfarin use in older patients receiving hemodialysis.
- Hispanic Ethnicity and Vascular Access Use in Patients Initiating Hemodialysis in the United States.
- Variation in initial Kidney replacement therapy for end-stage renal disease due to LN in the U.S.
- Air pollution and coronary risk in Kidney transplant recipients.
- Effectiveness and Safety of Warfarin Initiation in Older Hemodialysis Patients with Incident Atrial Fibrillation.
- Predialysis Nephrology Care of Older Patients Approaching End-stage Renal Disease.
- Angiotensin-converting enzyme inhibitors and cardiovascular outcomes in patients on maintenance hemodialysis.
- End-stage Renal disease due to lupus nephritis among children in the U.S., 1995-2006.
- Posttransplantation anemia: mechanisms and management.
- Incidence, correlates, and consequences of Acute kidney injury in patients with pulmonary arterial hypertension hospitalized with Acute right-side heart failure.
- Trends in the Use and Outcomes of Implantable Cardioverter-Defibrillators in Patients Undergoing Dialysis in the United States.
- Quantifying the benefit of early living-donor Renal transplantation with a simulation model of the Dutch Renal replacement therapy population.
- The effect of altitude change on anemia treatment response in hemodialysis patients.
- The 2011 ESRD prospective payment system: an uncontrolled experiment.
- Kidney function and long-term medication adherence after myocardial infarction in the elderly.
- Trends in the incidence, demographics and outcomes of end-stage Renal disease due to lupus nephritis in the U.S., 1995-2006.
- The increasing prevalence of atrial fibrillation among hemodialysis patients.
- Tackling the Achilles' heel of hemodialysis.
- Comparative effectiveness of calcium-containing phosphate binders in incident U.S. dialysis patients.
- Against TREATing all patients alike: lessons from an FDA Advisory Committee Meeting.
- The challenges of cost-effectiveness analyses for the clinician.
- Off-label use of phosphate binders in non-dialysis-dependent CKD.
- Confusion about the appropriate use of erythropoiesis-stimulating agents in patients undergoing maintenance dialysis.
- Kidney disease and antihypertensive medication adherence: the need for improved measurement tools.
- On the relative safety of intravenous iron formulations: new answers, new questions.
- Medication issues in older individuals with CKD.
- Comparative mortality risk of anemia management practices in incident hemodialysis patients.
- Effect of hemodialysis before transplant surgery on Renal allograft function--a pair of randomized controlled trials.
- Chronic on Acute renal failure: long-term implications of severe Acute kidney injury.
- Evolving statistical methods to facilitate evaluation of the causal association between erythropoiesis-stimulating agent dose and mortality in nonexperimental research...
- Lessons from geographic variations in predialysis nephrology care.
- Altitude and all-cause mortality in incident dialysis patients.
- Nonselective and cyclooxygenase-2-selective NSAIDs and Acute kidney injury.
- Comparison of cardiovascular outcomes in elderly patients with diabetes who initiated rosiglitazone vs pioglitazone therapy.
- Associations of Kidney function with cardiovascular medication use after myocardial infarction.
- The effect of altitude on dosing and response to erythropoietin in ESRD.
- Gender differences in the management and prognosis of myocardial infarction among patients > or = 65 years of age.
- Educational level as a determinant of access to and outcomes after Kidney transplantation in the United States.
- Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis.
- Approaching the end of the homocysteine hype?
- Phosphate binder choice in dialysis patients: a call for evidence-based rather than marketing-based clinical practice.
- Pottransplantation anemia: management and rationale.
- Medication adherence after myocardial infarction: a long way left to go.
- Ten-year trends of cardiovascular drug use after myocardial infarction among community-dwelling persons > or =65 years of age.
- Cardiovascular risk and the thiazolidinediones: déjà vu all over again?
- Impact of Medicaid prior authorization on angiotensin-receptor blockers: can policy promote rational prescribing?
- Nononcologic use of human recombinant erythropoietin therapy in hospitalized patients.
- The association between angiotensin converting enzyme inhibitor or angiotensin receptor blocker use during postischemic Acute transplant failure and renal allograft su...
- Angiotensin inhibition after myocardial infarction: does drug class matter?
- Efficacy and safety of angiotensin II receptor blockade in elderly patients with diabetes.
- Kidney function and use of recommended medications after myocardial infarction in elderly patients.
- Surrogate markers in clinical studies: problems solved or created?
- Validity of International Classification of Diseases, Ninth Revision, Clinical Modification Codes for Acute Renal Failure.
- Epoetin Alfa and Outcomes in Dialysis amid Regulatory and Payment Reform.
- Differences in initial treatment modality for end-stage Renal disease among glomerulonephritis subtypes in the USA.
- Comparative Effectiveness of Iron and Erythropoiesis-Stimulating Agent Dosing on Health-Related Quality of Life in Patients Receiving Hemodialysis.
Procedures Preformed
- Hemodialysis
- Peritoneal Dialysis
Conditions Treated
- Acute Kidney Failure
- Chronic Kidney Diseases
- End-Stage Renal Disease
- Gout
- View All
Doctors Specialties
- Nephrology
Accepted Insurances
Awards
- Fellow (ASNF)
Hospital
-
Stanford Health Care
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1871757021 |
| Last Name Of The Provider | WINKELMAYER |
| First Name Of The Provider | WOLFGANG |
| View All |
Similar Doctors
|
|
Dr. Neiha Arora, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Poojitha R. Beravol, MD |
|
|
Dr. Sean M. Wu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Emilee Wilhelm-Leen, MD |
|
|
Dr. Jeffrey Petersen, MD |
|
|
Dr. Vivek Bhalla, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jay P. Garg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maria-Gabriela Velez, MD |
|
|
Wael F. Hussein |